213627-30-6

Basic information

• Product Name: 4-BROMOBENZYLMETHYLSULFONE
• Synonyms: 4-BROMOBENZYLMETHYLSULFONE;1-bromo-4-(methylsulfonylmethyl)benzene
• CAS NO: 213627-30-6
• Molecular Formula: C₈H₉BrO₂S
• Molecular Weight: 249.12
• Mol File: 213627-30-6.mol
• Article Data: 13

Chemical Properties

• Melting Point: 134-136°C
• Boiling Point: 409.0±28.0 °C(Predicted)
• Appearance: /
• Density: 1.562±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 4-BROMOBENZYLMETHYLSULFONE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMOBENZYLMETHYLSULFONE(213627-30-6)
• EPA Substance Registry System: 4-BROMOBENZYLMETHYLSULFONE(213627-30-6)

Safety Data

• Hazardous Substances Data: 213627-30-6(Hazardous Substances Data)

Usage

General Description

4-Bromobenzylmethylsulfone is a chemical compound with the formula C8H9BrO2S. It is commonly used as a reagent in organic synthesis and pharmaceutical research. 4-BROMOBENZYLMETHYLSULFONE has been studied for its potential applications in the treatment of various medical conditions, including inflammation, pain, and oxidative stress-related disorders. It is also utilized in the development of new drugs and therapeutic agents. Additionally, 4-Bromobenzylmethylsulfone may be used as an intermediate in the production of other chemicals and pharmaceutical products. Due to its versatile properties and potential therapeutic benefits, this compound is a subject of ongoing research and exploration in the field of medicinal chemistry.

Upstream product

• 1122-91-4 4-bromo-benzaldehyde 
• 2386-57-4 methanesulfonic acid sodium salt 
• 589-15-1 1-bromomethyl-4-bromobenzene 
• 873-75-6 4-bromobenzenemethanol 
• 20277-69-4 sodium methansulfinate 
• 15733-07-0 1-bromo-4-(methylsulfanylmethyl)benzene 

Relevant articles and documents

NOVEL APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS

The present invention relates to inhibitors of apoptosis signal-regulating kinase 1 ("ASK1"), a process for synthesis of the compounds of the present invention, composition comprising the compounds and use of the compounds for inhibition of ASK1.

Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitors

Novel conformationally constrained BET bromodomain inhibitors have been developed. These inhibitors were optimized in two similar, yet distinct chemical series, the 6-methyl-1H-pyrrolo[2,3-c]pyridin-7(6H)-ones (A) and the 1-methyl-1H-pyrrolo[2,3-c]pyridin

DIHYDRO-PYRROLOPYRIDINONE INHIBITORS

The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, and R5 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).